TLR5 and metabolic syndrome: For instance, we [25] and others [32] have not observed any evidence of intestinal inflammation, metabolic syndrome or measurable bacterial translocation across the mucosal barrier in tumor-bearing mice housed in our facilities, including TLR5-deficient animals.